IDH1 and chondrosarcoma: This efficacy could be biased by the general indolent behavior of IDH1mut tumors compared to wild-type IDH1 tumors, but retrospective studies had not clearly defined if the IDH1 mutation could have a prognostic role in chondrosarcomas [131,132].